Inovio Pharmaceuticals
INO
INO
114 hedge funds and large institutions have $142M invested in Inovio Pharmaceuticals in 2015 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 41 increasing their positions, 31 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0.14% more ownership
Funds ownership: 3.26% → 3.4% (+0.14%)
26% less capital invested
Capital invested by funds: $192M → $142M (-$50.3M)
Holders
114
Holding in Top 10
–
Calls
$5.94M
Puts
$3.46M
Top Buyers
| 1 | +$2.5M | |
| 2 | +$2.37M | |
| 3 | +$1.65M | |
| 4 |
Capstone Investment Advisors
New York
|
+$1.45M |
| 5 |
RCM
Rotella Capital Management
Bellevue,
Washington
|
+$1.31M |
Top Sellers
| 1 | -$4.51M | |
| 2 | -$2.86M | |
| 3 | -$1.75M | |
| 4 |
GC
Globeflex Capital
San Diego,
California
|
-$996K |
| 5 |
SM
Sabby Management
Miami Beach,
Florida
|
-$974K |